71 results
10-K
2014 FY
NVRO
Nevro Corp
18 Mar 15
Annual report
12:00am
considered non-responders in this analysis population.
Per Protocol (PP; n=179)—All randomized subjects who completed a primary endpoint assessment … % of traditional SCS therapy participants. Importantly, neurological assessment revealed no stimulation-related neurological deficits in either treatment
424B4
sdop23y
6 Nov 14
Prospectus supplement with pricing info
12:00am
S-1
vkyuibib0 34ly
3 Oct 14
IPO registration
12:00am
DRS/A
67yxw lqm8zu
16 Sep 14
Draft registration statement (amended)
12:00am
S-1/A
m1t9 ghsm3j8klvp
10 Oct 14
IPO registration (amended)
12:00am
10-Q
ce6s5
2 Dec 14
Quarterly report
12:00am
PRE 14A
j3md2 tg9o9vlhktbxc9
29 Mar 19
Preliminary proxy
4:53pm